Verification vs. Validation – Product¸ Process or Equipment, Software and QMS

Duration 90 Mins
Level Basic & Intermediate
Webinar ID IQW15C6628

  • Verification and validation requirements, US and EU
  • “Working definitions”
  • VMP, IQ, OQ and PQ and their equivalents
  • From Requirements to test cases/test scripts
  • Putting it all together – a company system, and an individual test report
 

Overview of the webinar

Review a company's Verification and Validation System for major cGMP deficiencies. Address the FDA's newer and tougher regulatory stance. One major failing is lack of sufficient or targeted risk-based V&V planning. Starting with a Master Validation Plan, evaluating its elements against ISO 14971 and ICH Q9 for hazard analysis and product risk management allows the development of meaningful product and process validations. Also the role of the individual V&V plan, and different protocols; how to employ equipment/process DQs, IQs, OQs, and PQs, or their equivalents, against a background of limited company resources.  Our matrix simplifies "as-product", in-product", process and equipment, et al, software VT&V, assuring key FDA requirements are not overlooked. The QMS and 21 CFR Part 11 are also considered. Formal ISO and CGMP definitions vs. “working definitions”. The end result of this webinar will be a format for a working V&V system, field-tested over decades, for all regulated industries, and US FDA CGMP and EU compliant.

Who should attend?

  • Senior management
  • Middle management / staff
  • Operations / manufacturing
  • R&D
  • Engineering
  • QA / RA

Why should you attend?

FDA Warning Letters and recent high-profile recalls indicate major cGMP deficiencies in big-name device and pharma companies. One major failing is lack of sufficient or targeted risk-based V&V planning and execution. But a review of Internet forums shows confusion as to what is V&V planning. What really is a Master Validation Plan? Why do companies need one? What are the individual V&V plan and its high value? What are verification activities? Validation? Qualifications? IQ, OQ, PQs? Commissioning? FAT, SAT? How to translate Requirements into IQ, QO, and PQ test cases/scripts. What are the "must have" elements from  ISO 14971 and ICH Q9 for hazard analysis and product risk management? How can these be integrated?

Faculty - Mr.John E. Lincoln

John E. Lincoln, is Principal of J. E. Lincoln and Associates LLC, a consulting company with over 33 years experience in U.S. FDA-regulated industries, 19 of which are as an independent consultant. John has worked with companies from start-up to Fortune 100, in the U.S., Mexico, Canada, France, Germany, Sweden, China and Taiwan.  He specializes in quality assurance, regulatory affairs, QMS problem remediation and FDA responses, new / changed product 510(k)s, process / product / equipment including QMS and software validations, ISO 14971 product risk management files / reports, Design Control / Design History Files, Technical Files, CAPA systems and analysis.  He's held positions in Manufacturing Engineering, QA, QAE, Regulatory Affairs, to the level of Director and VP (R&D).  In addition, John has prior experience in military, government, electronics, and aerospace.  He has ptublished numerous articles in peer reviewed journals, conducted workshops and webinars worldwide on CAPA, 510(k)s, risk analysis / management, FDA / GMP audits, validation, root cause analysis, and others. He writes a recurring column for the Journal of Validation Technology. John is a graduate of UCLA.

100% MONEY BACK GUARANTEED

Refund / Cancellation policy
For group or any booking support, contact: